STING1 and cancer: Loss‐of‐function has been seen in STING and cGAS, and cancer may hijack epigenetic inactivation of cGAS/STING signaling to evade immune surveillance in facilitating tumorigenesis.[3, 44] Hence, pharmacological activation of this signaling has been proposed to be a promising anti‐cancer strategy.